Uncategorized Archives - Page 26 of 251

FridayMar 03, 2023 10:30 am

India Globalization Capital Inc. (NYSE American: IGC) Leads the Way Forward with Revolutionary Cannabis-Based Treatment for Alzheimer’s Symptoms

Company’s investigational drug is being tested for the first time ever on humans in an FDA-approved study In phase 1 studies, IGC-AD1 shows potential to safely reduce debilitating symptoms IGC is actively building a portfolio of both cannabis-based and manufactured molecules that can address multiple areas of unmet medical needs In groundbreaking work that establishes its commitment to being a pioneer in the treatment of Alzheimer’s disease, India Globalization Capital (NYSE American: IGC) is developing a cannabis-based investigational drug that is being tested for the first time ever on humans in an FDA-approved study (https://cnw.fm/6qps2). The company is developing its…

ThursdayMar 02, 2023 9:45 am

Lexaria Bioscience Corp. (NASDAQ: LEXX) Uses Patented DehydraTECH(TM) Technology to Disrupt Drug Delivery Through Innovation

Lexaria's DehydraTECH(TM) technology has 28 granted patents, with many more patents pending worldwide DehydraTECH(TM) uses a patented formulation and dehydration process method to change how the body detects and absorbs drugs Lexaria is focusing on three main areas: CBD for hypertension, oral nicotine to replace vaping and smoking, and CBD potentially for diabetes and seizures Lexaria is conducting early work to support its FDA-registered IND program to investigate DehydraTECH(TM)-processed CBD for hypertension Lexaria Bioscience (NASDAQ: LEXX), a global innovator in drug delivery platforms, is increasing the bioavailability and improving the way active pharmaceutical ingredients (“APIs”) enter the bloodstream through its…

WednesdayMar 01, 2023 10:30 am

Prime Harvest Inc. Reveals That Their Reg A+ Equity Offering Has Been Granted Approval to Go Ahead

Prime Harvest recently revealed that the company’s Reg A+ equity offering has been greenlighted by the SEC The primary share offering will see the company market up to 10 million shares to investors at a price of $4.20 each, with estimated gross proceeds of $42 million The company has said that net proceeds will be destined towards the acquisition of licensed assets, continued expansion of their delivery network and general corporate purposes Prime Harvest, a technology-focused, full-service cannabis company based in San Diego, recently announced the qualification of its equity offering under the SEC’s Regulation A+. The offering, which has…

WednesdayMar 01, 2023 9:00 am

Explore all things cannabis at CannExpo March 25-26 at Enercare Centre

Toronto’s premiere destination for canna-curious and enthusiasts alike CannExpo Toronto, a consumer and retail cannabis show taking place March 24-26th, 2023 at the Enercare Centre, will feature three full days of exhibits and events for cannabis consumers, licensed retailers and budtenders. Visitors can discover new products and cutting edge technology, plus purchase accessories, hardware and services. Exhibitors include popular cannabis brands such as Slow Ride Bakery, Shatterizer and Weed Me Inc., Licensed Retail Stores including Canada’s first cannabis store owned by a Woman of Colour; GreenPort, craft growers, accessories, cannabis crafts, organic hemp products and more. The Ontario Cannabis Store…

TuesdayFeb 28, 2023 11:15 am

Alternative Products Expo at Ft. Lauderdale, Coming Up Soon

The Alternatives Products Expo, organized by ZJ Events is being held in Fort Lauderdale March 3-5, 2023. Exhibitors can showcase their products and market their innovative ideas in front of a large audience of potential investors. This premier counterculture show will feature a diverse range of products including CBD, DELTA-8, Nicotine Alternatives, Kratom, Extracts, Functional Beverages, and more. The Alternative Products Expo will offer participants a unique experience, offering access to new products and free samples available only at the show, as exhibitors pitch their services, products, and ideas to expand the attendees' knowledge base. All mainstream products have an…

TuesdayFeb 28, 2023 9:45 am

REZYFi, Inc. Delivers on Promise of Expertise, Focusing on Loan Origination and Support for Cannabis, High-risk Clients

Specialized mortgage lender REZYFi Inc. is strategically serving the needs of consumers and cannabis-related businesses through an alternative loan financing approach The company’s alternative mortgage financing strategy relies on real estate and other assets of the borrowers to secure loans for clients whose financial history or legal revenue base may make them unattractive borrowers for traditional banks The cannabis industry has long struggled to secure loans despite its cash-intensive operations because of the federal government’s choice not to recognize the industry REZYFi’s strengths as a lender include efficient operations supported by skilled staffing with years of expertise in the industry,…

MondayFeb 27, 2023 10:30 am

Lexaria Bioscience Corp.’s (NASDAQ: LEXX) Additional HYPER-H21-4 Study Findings Offer Better Understanding of the Anti-Hypertensive Effects of DehydraTECH-CBD

Dosing for Lexaria’s ambitious and most comprehensive clinical study, HYPER-H21-4, was successfully completed in July 2022, with newly analyzed results now emerging Its latest findings bring the company closer to its upcoming FDA Phase 1b study while also explaining the patented DehydraTECH-(TM)-processed CBD interaction with the sympatho-chromaffin system via catestatin modulation Lexaria’s management is optimistic that DehyraTECH-CBD and its effectiveness in modulating catestatin levels could become a significant value enhancer should it eventually enter the marketplace as an approved hypertension treatment Lexaria Bioscience (NASDAQ: LEXX), a global innovator in drug delivery platforms, kicked off its human clinical study, HYPER-H21-1 in…

ThursdayFeb 23, 2023 9:45 am

Lexaria Bioscience Corp. (NASDAQ: LEXX) Looking Forward to 2023 Goals for Patented DehydraTECH(TM) Technology

Lexaria’s 2022 R&D efforts saw high levels of success, establishing the company as one of the world’s leaders in the investigation of CBD for controlling human blood pressure and, separately, demonstrating performance enhancements compared to one of the world's leading anti-seizure medications During Q1 2023, Lexaria expects to provide additional results from its hypertension study HYPER-H21-4; complete dosing in the company’s animal dementia and diabetes studies; complete dosing in the human nicotine study NIC-H21-1; and submit and publish additional results in research journals Lexaria’s DehydraTECH technology currently has 28 granted patents, with many more pending patents in countries worldwide Lexaria…

TuesdayFeb 21, 2023 10:30 am

REZYFi, Inc. Stands Ready to Provide Much-Needed Capital to Cannabis Companies as Softening Mortgage Rates Boost Opportunities for Refinancing

REZYFi is a real estate-oriented mortgage company servicing the needs of licensed and permitted cannabis companies and owners of real estate who lease to cannabis companies The average rate on a 30-year-fixed-rate mortgage, measured weekly, has been declining gradually since October last year, increasing the market for new and refinanced mortgages Mortgage refinancing can be a source of capital, presenting an important financing opportunity for business operators in the cannabis space who struggle to access money from traditional banks In the months since the US average rate on a 30-year-fixed-rate mortgage peaked at more than 7.10% in October last year,…

TuesdayFeb 21, 2023 9:45 am

Lexaria Bioscience Corp. (NASDAQ: LEXX) Continues to Foster New Partnerships with its Expanding DehydraTECH(TM) Licensing Opportunities

Lexaria’s patented DehydraTECH(TM) technology improves how APIs enter the bloodstream through the promotion of healthier oral ingestion methods while also increasing the effectiveness of fat-soluble active molecules As a disruptive technology, its impact has been felt by other players in its space, leading Lexaria to open its doors to partnering with industry experts and implementing the technology across many fields, including licensing the technology to Fortune 100 companies Lexaria will continue to make its technology accessible, improving the lives of people around the world Lexaria Bioscience (NASDAQ: LEXX), a global innovator in drug delivery platforms, has, since 2016, repeatedly demonstrated…

News and publishing service for cannabis related companies

Contact us: 512.354.7000

Category: Uncategorized